Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N FIESSINGER

Showing results (291-300 of 315) with videos related to

Pageof 32
Sort By:
Journal of Thrombosis and Haemostasis : JTH|August 12, 2004
The factor II G20210A gene polymorphism, but not factor V Arg506Gln, is associated with peripheral arterial disease: results of a case-control studyJ L Reny, M Alhenc-Gelas, P Fontana, et al.
British Journal of Haematology|July 1, 1991
Molecular basis for hereditary antithrombin III quantitative deficiencies: a stop codon in exon IIIa and a frameshift in exon VIS Gandrille, D Vidaud, J Emmerich, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 11, 1999
Complex association of protein C gene promoter polymorphism with circulating protein C levels and thrombotic riskM Aiach, V Nicaud, M Alhenc-Gelas, et al.
Journal of Vascular Surgery|July 1, 1995
Percutaneous transluminal angioplasty for emboligenic arterial lesions after radiotherapy of axillary arteriesC Veyssier-Belot, J Emmerich, M R Sapoval, et al.
Annales De Biologie Clinique|January 1, 1985
[Biological profile of the 1st 4 hours of a thrombolytic treatment combining urokinase with lysyl-plasminogen]M Roncato, J F Vitoux, J M Pernes, et al.
British Journal of Haematology|October 16, 1999
Influence of three potential genetic risk factors for thrombosis in 43 families carrying the factor V Arg 506 to Gln mutationV Le Cam-Duchez, S Gandrille, D Trégouët, et al.
La Revue De Medecine Interne|May 18, 1999
[Immediate results and 2-year follow-up of percutaneous transluminal angioplasty in intermittent claudication in patients over 70 years of age]J G Velut, E Héron, J Emmerich, et al.
Human Mutation|January 1, 1992
Two novel mutations responsible for hereditary type I protein C deficiency: characterization by denaturing gradient gel electrophoresisS Gandrille, M Vidaud, M Aiach, et al.
The Journal of Biological Chemistry|November 5, 1990
Important role of arginine 129 in heparin-binding site of antithrombin III. Identification of a novel mutation arginine 129 to glutamineS Gandrille, M Aiach, D A Lane, et al.
Thrombosis and Haemostasis|March 4, 1999
The factor V gene A4070G mutation and the risk of venous thrombosisM Alhenc-Gelas, V Nicaud, S Gandrille, et al.
Pageof 32

Showing results (291-300 of 315) with videos related to

Sort By:
Pageof 32
Journal of Thrombosis and Haemostasis : JTH|August 12, 2004
The factor II G20210A gene polymorphism, but not factor V Arg506Gln, is associated with peripheral arterial disease: results of a case-control studyJ L Reny, M Alhenc-Gelas, P Fontana, et al.
British Journal of Haematology|July 1, 1991
Molecular basis for hereditary antithrombin III quantitative deficiencies: a stop codon in exon IIIa and a frameshift in exon VIS Gandrille, D Vidaud, J Emmerich, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 11, 1999
Complex association of protein C gene promoter polymorphism with circulating protein C levels and thrombotic riskM Aiach, V Nicaud, M Alhenc-Gelas, et al.
Journal of Vascular Surgery|July 1, 1995
Percutaneous transluminal angioplasty for emboligenic arterial lesions after radiotherapy of axillary arteriesC Veyssier-Belot, J Emmerich, M R Sapoval, et al.
Annales De Biologie Clinique|January 1, 1985
[Biological profile of the 1st 4 hours of a thrombolytic treatment combining urokinase with lysyl-plasminogen]M Roncato, J F Vitoux, J M Pernes, et al.
British Journal of Haematology|October 16, 1999
Influence of three potential genetic risk factors for thrombosis in 43 families carrying the factor V Arg 506 to Gln mutationV Le Cam-Duchez, S Gandrille, D Trégouët, et al.
La Revue De Medecine Interne|May 18, 1999
[Immediate results and 2-year follow-up of percutaneous transluminal angioplasty in intermittent claudication in patients over 70 years of age]J G Velut, E Héron, J Emmerich, et al.
Human Mutation|January 1, 1992
Two novel mutations responsible for hereditary type I protein C deficiency: characterization by denaturing gradient gel electrophoresisS Gandrille, M Vidaud, M Aiach, et al.
The Journal of Biological Chemistry|November 5, 1990
Important role of arginine 129 in heparin-binding site of antithrombin III. Identification of a novel mutation arginine 129 to glutamineS Gandrille, M Aiach, D A Lane, et al.
Thrombosis and Haemostasis|March 4, 1999
The factor V gene A4070G mutation and the risk of venous thrombosisM Alhenc-Gelas, V Nicaud, S Gandrille, et al.
Pageof 32